Catalog Number VBJR080502A |
Device Problem
Insufficient Information (3190)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 12/07/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).A review of the manufacturing records for the device verified the lot met all pre-release specifications.According to the gore® viabahn® endoprosthesis with heparin bioactive surface instructions for use (ifu),complications and adverse events can occur when using any endovascular device.These complications include, but are not limited to: migrations.
|
|
Event Description
|
The following information was reported to gore: on (b)(6) 2017 a patient was undergoing treatment of a left arm av access proximal graft to distal subclavian vein thrombotic occlusion with apparent extravasation seen on contrast angio.A gore® viabahn® endoprosthesis with heparin bioactive surface was advanced over a.035" glidewire through a 7fr sheath.On (b)(6) 2017 it was reported imaging showed no viabahn in the area expected.Further imaging showed the viabahn in the superior vena cava.The patient is reportedly stable and there are no current plans for reintervention.
|
|
Manufacturer Narrative
|
Updated.
|
|
Event Description
|
On (b)(6) 2017 a patient was undergoing treatment of a left arm av access procedure.A gore® viabahn® endoprosthesis with heparin bioactive surface was advanced over a.035" glidewire through a 7fr sheath and deployed in the axillary vein, across the anastomosis with the av graft.Following the procedure, the viabahn was well-apposed to the both the axillary vein and the av graft.On (b)(6) 2017 it was reported imaging showed no viabahn in the area expected.Further imaging showed the viabahn in the pulmonary artery.On an unknown date the viabahn was explanted by an interventional radiologist through the internal jugular vein.The patient is reportedly doing well and is receiving dialysis treatments via a permacath.
|
|
Search Alerts/Recalls
|